Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0I7RA
|
|||
Former ID |
DNC009399
|
|||
Drug Name |
4-(5-Bromoindole-3-yl)-6,7-dimethoxyquinazoline
|
|||
Synonyms |
CHEMBL473320; 4-(5-Bromoindole-3-yl)-6,7-dimethoxyquinazoline; SCHEMBL5616932
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H14BrN3O2
|
|||
Canonical SMILES |
COC1=C(C=C2C(=C1)C(=NC=N2)C3=CNC4=C3C=C(C=C4)Br)OC
|
|||
InChI |
1S/C18H14BrN3O2/c1-23-16-6-12-15(7-17(16)24-2)21-9-22-18(12)13-8-20-14-4-3-10(19)5-11(13)14/h3-9,20H,1-2H3
|
|||
InChIKey |
MWBJNWJINFGNLQ-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Syntheses of 4-(indole-3-yl)quinazolines: a new class of epidermal growth factor receptor tyrosine kinase inhibitors. Eur J Med Chem. 2008 Jul;43(7):1478-88. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.